Condition: Influenza Immunization · Sponsor: Sanofi Pasteur, a Sanofi Company
The purpose of this study is to evaluate the safety and immunogenicity of a single intramuscular (IM) injection of different formulations of Quadrivalent Influenza Vaccine (QIV) messenger ribonucleic acid (mRNA) (MRT5421, MRT5424, and MRT5429) compared to an active control (QIV- standard dose (SD), QIV- high dose (HD) \[adults ≥ 65 years of age only\], or quadrivalent recombinant influenza vaccine (RIV4)) in adults 18 years of age and older.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Long Beach Clinical Trials Site Number : 8400013 | Long Beach, California, United States | — |
| California Research Foundation Site Number : 8400038 | San Diego, California, United States | — |
| Accel Clinical Research-Deland Clinical Research Unit- Site Number : 8400001 | DeLand, Florida, United States | — |
| SIMEDHealth, LLC- Site Number : 8400011 | Gainesville, Florida, United States | — |
| Indago Research and Health Center- Site Number : 8400032 | Hialeah, Florida, United States | — |
| Cenexel Research Centers of America- Site Number : 8400037 | Hollywood, Florida, United States | — |
| Suncoast Research Group, LLC- Site Number : 8400015 | Miami, Florida, United States | — |
| Brengle Family Medicine Site Number : 8400045 | Indianapolis, Indiana, United States | — |
| AMR Lexington- Site Number : 8400042 | Lexington, Kentucky, United States | — |
| Velocity Clinical Research- New Orleans Site Number : 8400053 | New Orleans, Louisiana, United States | — |
| The Alliance for Multispecialty Research - KCM, LLC- Site Number : 8400034 | Kansas City, Missouri, United States | — |
| Velocity Clinical Research Norfolk- Site Number : 8400046 | Norfolk, Nebraska, United States | — |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06361875